Accueil > Actualité
Actualite financiere : Actualite bourse

AstraZeneca: Fasenra approved for self-injection

( - AstraZeneca announced on Friday that the US Food and Drug Administration (FDA) has approved Fasenra's principle of self-administration in a pre-filled, single-use auto-injector.

This approval is supported by data from the GRECO Phase III trial and the AMES Phase I trial. The safety and tolerability of Fasenra in these trials were consistent with the established drug profile.

The self-administration of Fasenra and the Fasenra pen are also approved in the European Union.

Copyright (c) 2019 All rights reserved.




Qui sommes-nous ? | Nous contacter | FAQ | Mentions légales | RSS | © Copyright 2007 Cercle Finance. Tous droits réservés.
Indices et cours différés d’au moins 15 mn | Cotations boursières fournies par ABC Bourse.